ATE277606T1 - Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtrakt - Google Patents
Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtraktInfo
- Publication number
- ATE277606T1 ATE277606T1 AT98921690T AT98921690T ATE277606T1 AT E277606 T1 ATE277606 T1 AT E277606T1 AT 98921690 T AT98921690 T AT 98921690T AT 98921690 T AT98921690 T AT 98921690T AT E277606 T1 ATE277606 T1 AT E277606T1
- Authority
- AT
- Austria
- Prior art keywords
- gitterial
- tract
- film
- coated tablet
- improved tolerability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4930697P | 1997-06-11 | 1997-06-11 | |
PCT/IB1998/000883 WO1998056360A2 (en) | 1997-06-11 | 1998-06-08 | Film-coated tablet for improved upper gastrointestinal tract safety |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE277606T1 true ATE277606T1 (de) | 2004-10-15 |
Family
ID=21959131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98921690T ATE277606T1 (de) | 1997-06-11 | 1998-06-08 | Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtrakt |
Country Status (30)
Country | Link |
---|---|
US (4) | US6165513A (de) |
EP (1) | EP0989848B1 (de) |
JP (3) | JP5093937B2 (de) |
KR (1) | KR100400053B1 (de) |
CN (1) | CN1274279A (de) |
AR (1) | AR027158A1 (de) |
AT (1) | ATE277606T1 (de) |
AU (1) | AU729912B2 (de) |
BR (1) | BR9810027A (de) |
CA (1) | CA2293815C (de) |
CO (1) | CO4940409A1 (de) |
DE (1) | DE69826660T2 (de) |
DK (1) | DK0989848T3 (de) |
ES (1) | ES2226128T3 (de) |
HK (1) | HK1028187A1 (de) |
HU (1) | HUP0004625A1 (de) |
IL (2) | IL133405A0 (de) |
MY (1) | MY127526A (de) |
NO (1) | NO996116L (de) |
NZ (1) | NZ503946A (de) |
PE (1) | PE82999A1 (de) |
PL (1) | PL337813A1 (de) |
PT (1) | PT989848E (de) |
RU (1) | RU2193880C2 (de) |
SG (1) | SG108292A1 (de) |
SK (1) | SK284690B6 (de) |
TR (1) | TR200000111T2 (de) |
TW (1) | TW542725B (de) |
WO (1) | WO1998056360A2 (de) |
ZA (1) | ZA985010B (de) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE277606T1 (de) * | 1997-06-11 | 2004-10-15 | Procter & Gamble | Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtrakt |
AR024462A1 (es) | 1999-07-01 | 2002-10-02 | Merck & Co Inc | Tabletas farmaceuticas |
PE20011061A1 (es) * | 2000-02-01 | 2001-11-20 | Procter & Gamble | Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato |
US20060269602A1 (en) * | 2001-04-13 | 2006-11-30 | Dasch James R | Method of modifying the release profile of sustained release compositions |
US6558702B2 (en) * | 2001-04-13 | 2003-05-06 | Alkermes Controlled Therapeutics, Inc. | Method of modifying the release profile of sustained release compositions |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
DE10129674A1 (de) * | 2001-06-20 | 2003-01-16 | Lohmann Gmbh & Co Kg | Hydrokolloidzusammensetzungen sowie deren Verwendung zur Herstellung redispergierbarer Beschichtungen, Filme, Folien oder Papiere |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
US20050070504A1 (en) * | 2001-12-21 | 2005-03-31 | The Procter & Gamble Co. | Risedronate compositions and their methods of use |
EP1465606A4 (de) | 2001-12-24 | 2009-04-22 | Teva Pharma | Dosierungsform mit einem von einem verpressten ringförmigen körper aus pulver- oder granulatmaterial umhüllten tablettenkern aus aktivem bestandteil sowie verfahren und gerät zur herstellung davon |
PL372964A1 (en) * | 2002-04-11 | 2005-08-08 | Teva Pharmaceutical Indudstries, Ltd. | Novel polymorphs and pseudopolymorphs of risedronate sodium |
US20040048877A1 (en) * | 2002-05-22 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions containing flibanserin |
EP1396263A1 (de) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Filmüberzüge für Tabletten oder Caplets |
US20040043072A1 (en) * | 2002-09-04 | 2004-03-04 | Will Joanne Patricia | Alleviation of upper gastrointestinal irritation |
SI1596870T2 (sl) * | 2002-12-20 | 2011-07-29 | Hoffmann La Roche | Formulacija z visokim odmerkom ibandronata |
TR200300510A2 (tr) * | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
CA2533150C (en) | 2003-07-25 | 2013-03-12 | Warner Chilcott Company, Inc. | A doxycycline metal complex in a solid dosage form |
WO2005023270A2 (en) * | 2003-09-09 | 2005-03-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
KR20060058134A (ko) * | 2003-09-19 | 2006-05-29 | 화이자 프로덕츠 인코포레이티드 | 2-알킬리덴-19-노르-비타민 디 유도체 및비스포스포네이트의 조합을 포함하는 약학 조성물 및 방법 |
WO2005046651A1 (en) * | 2003-11-12 | 2005-05-26 | Ranbaxy Laboratories Limited | Liquid filled capsules of doxycycline |
US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
MXPA06012059A (es) * | 2004-04-22 | 2007-01-25 | Boehringer Ingelheim Int | Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii. |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
US20050260272A1 (en) * | 2004-05-05 | 2005-11-24 | Alkermes Controlled Therapeutics, Inc. | Method of forming microparticles that include a bisphosphonate and a polymer |
WO2006020009A1 (en) * | 2004-07-23 | 2006-02-23 | The Procter & Gamble Company | Solid oral dosage form of a bisphosphonate containing a chelating agent |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
JP2008511569A (ja) * | 2004-09-03 | 2008-04-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 注意欠如活動過多障害の治療方法 |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
US7358361B2 (en) * | 2004-10-08 | 2008-04-15 | The Board Of Trustees Of The University Of Illinois | Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
US8012949B2 (en) * | 2004-10-08 | 2011-09-06 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS |
US20070271153A1 (en) * | 2004-12-23 | 2007-11-22 | Amit Goel | Method and system of aggregating listings for sale |
AU2006206359B2 (en) * | 2005-01-21 | 2011-03-31 | Allergan Pharmaceuticals International Limited | A tetracycline metal complex in a solid dosage form |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
CA2599721A1 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
EP1858515A2 (de) * | 2005-03-04 | 2007-11-28 | Boehringer Ingelheim International Gmbh | Pharmazeutische zusammensetzungen zur behandlung und/oder vorbeugung von mit angstzuständen verbundenen erkrankungen |
EP1867324B1 (de) * | 2005-03-31 | 2016-07-13 | Takeda Pharmaceutical Company Limited | Tablette |
CA2608249A1 (en) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug abuse with flibanserin |
CA2608363A1 (en) * | 2005-05-19 | 2006-11-23 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug-induced sexual dysfunction |
CA2608713A1 (en) * | 2005-05-19 | 2006-11-23 | Boehringer Ingelheim International Gmbh | Method for the treatment of sexual dysfunctions due to medical conditions |
US8722650B1 (en) | 2005-06-24 | 2014-05-13 | Medicis Pharmaceutical Corporation | Extended-release minocycline dosage forms |
US7544373B2 (en) * | 2007-04-02 | 2009-06-09 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US20080242642A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US8252776B2 (en) | 2007-04-02 | 2012-08-28 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US20080241235A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US7541347B2 (en) | 2007-04-02 | 2009-06-02 | Medicis Pharmaceutical Coropration | Minocycline oral dosage forms for the treatment of acne |
US7919483B2 (en) * | 2005-06-24 | 2011-04-05 | Medicis Pharmaceutical Corporation | Method for the treatment of acne |
JP2009503020A (ja) | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肥満症の治療におけるフリバンセリンの使用 |
WO2007048803A1 (en) * | 2005-10-29 | 2007-05-03 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
US7964215B1 (en) * | 2006-01-24 | 2011-06-21 | Emet Pharmaceuticals, LLC | Delayed release dosage form |
CA2646334A1 (en) * | 2006-03-17 | 2007-09-27 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods |
WO2007128802A2 (en) * | 2006-05-09 | 2007-11-15 | Boehringer Ingelheim International Gmbh | Use of flibanserin for the treatment of post-menopausal sexual desire disorders |
JP2009541443A (ja) | 2006-06-30 | 2009-11-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 尿失禁及び関連疾患の治療のためのフリバンセリン |
CA2657043A1 (en) * | 2006-07-14 | 2008-01-17 | Boehringer Ingelheim International Gmbh | Use of flibanserin for the treatment of sexual disorders in females |
EA200900264A1 (ru) * | 2006-08-14 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Композиции флибансерина и способ их приготовления |
CL2007002214A1 (es) * | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
EA200900270A1 (ru) * | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
JP5676834B2 (ja) * | 2006-11-29 | 2015-02-25 | エスエス製薬株式会社 | 消化管への刺激性を減少した経口固形組成物 |
US20080241197A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline dosage forms for the treatment of acne |
JP5441354B2 (ja) * | 2007-05-23 | 2014-03-12 | キヤノン株式会社 | インクセット、インクジェット記録方法、インクカートリッジ及びインクジェット記録装置 |
WO2009018834A1 (en) * | 2007-08-06 | 2009-02-12 | Pharmathen S.A. | Pharmaceutical composition containing bisphosphonate and method for the preparation thereof |
PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
WO2010017310A1 (en) | 2008-08-06 | 2010-02-11 | Medicis Pharmaceutical Corporation | Method for the treatment of acne and certain dosage forms thereof |
CA2769633C (en) | 2009-07-31 | 2017-06-06 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
CA3029948C (en) * | 2010-09-21 | 2021-06-15 | Intekrin Therapeutics, Inc. | Antidiabetic solid pharmaceutical compositions |
WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US9561241B1 (en) | 2011-06-28 | 2017-02-07 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for minocycline |
WO2013015599A2 (en) * | 2011-07-28 | 2013-01-31 | Yuhan Corporation | Pharmaceutical composition for oral administration comprising bisphosphonic acid or its salt |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
EP2983657B1 (de) * | 2013-04-05 | 2020-06-03 | Numedii, Inc. | Nadololformulierungen zur behandlung von chronish-entzündlichen darmerkrankungen |
WO2016020336A1 (en) * | 2014-08-04 | 2016-02-11 | Dbv Technologies | Compositions of food allergens |
USD787042S1 (en) * | 2015-04-28 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
USD787043S1 (en) * | 2015-06-23 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
USD816506S1 (en) | 2015-11-02 | 2018-05-01 | Pura Scents, Inc. | Vial for a scent dispenser |
CN113952494A (zh) | 2015-11-02 | 2022-01-21 | 普拉辛兹有限公司 | 气味分配器 |
USD809116S1 (en) | 2015-11-02 | 2018-01-30 | Pura Scents | Dispenser |
US10314514B2 (en) * | 2016-05-29 | 2019-06-11 | Ankon Medical Technologies (Shanghai) Co., Ltd. | System and method for using a capsule device |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
BR112019002120A2 (pt) * | 2016-08-08 | 2019-05-14 | Hetero Labs Limited | composição anti-retroviral de várias classes |
BR112019002132A2 (pt) | 2016-08-08 | 2019-05-14 | Hetero Labs Limited | composições anti-retrovirais |
USD813372S1 (en) | 2017-02-22 | 2018-03-20 | Celgene Corporation | Pharmaceutical tablet |
USD835257S1 (en) | 2017-02-22 | 2018-12-04 | Celgene Corporation | Pharmaceutical tablet |
USD906513S1 (en) * | 2019-03-19 | 2020-12-29 | Novo Nordisk A/S | Pill |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161530A (en) * | 1975-01-06 | 1979-07-17 | Ciba-Geigy Corporation | Pharmaceutical combination preparations as hypnotics |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
US4302440B1 (en) * | 1980-07-31 | 1986-08-05 | Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof | |
DE8622513U1 (de) * | 1986-02-24 | 1986-10-30 | Smithkline Beckman Corp., Philadelphia, Pa. | Tablette |
AU622254B2 (en) * | 1989-01-03 | 1992-04-02 | Sterling Drug Inc. | Controlled-release, low dose aspirin |
NZ233403A (en) * | 1989-04-28 | 1992-09-25 | Mcneil Ppc Inc | Simulated capsule-like medicament |
PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
US5146730A (en) * | 1989-09-20 | 1992-09-15 | Banner Gelatin Products Corp. | Film-enrobed unitary-core medicament and the like |
ATE195075T1 (de) * | 1991-11-22 | 2000-08-15 | Procter & Gamble Pharma | Risedronat enthaltende arzneimittel mit verzögerter wirkstoffabgabe |
TW237386B (de) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
FR2738833B1 (fr) * | 1995-09-14 | 1997-12-05 | Seppic Sa | Composition filmogene pour le masquage de gout destinee a l'enrobage de formes solides ingerables telles qu'en particulier des comprimes pharmaceutiques |
DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
ATE277606T1 (de) * | 1997-06-11 | 2004-10-15 | Procter & Gamble | Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtrakt |
JPH11246392A (ja) * | 1998-03-03 | 1999-09-14 | Makoto Otsuka | 経口用固形製剤 |
-
1998
- 1998-06-08 AT AT98921690T patent/ATE277606T1/de active
- 1998-06-08 TR TR2000/00111T patent/TR200000111T2/xx unknown
- 1998-06-08 HU HU0004625A patent/HUP0004625A1/hu not_active Application Discontinuation
- 1998-06-08 NZ NZ503946A patent/NZ503946A/xx not_active IP Right Cessation
- 1998-06-08 PT PT98921690T patent/PT989848E/pt unknown
- 1998-06-08 SK SK1718-99A patent/SK284690B6/sk not_active IP Right Cessation
- 1998-06-08 DK DK98921690T patent/DK0989848T3/da active
- 1998-06-08 SG SG200200225A patent/SG108292A1/en unknown
- 1998-06-08 EP EP98921690A patent/EP0989848B1/de not_active Revoked
- 1998-06-08 KR KR10-1999-7011668A patent/KR100400053B1/ko active IP Right Review Request
- 1998-06-08 AU AU74460/98A patent/AU729912B2/en not_active Expired
- 1998-06-08 WO PCT/IB1998/000883 patent/WO1998056360A2/en active IP Right Grant
- 1998-06-08 BR BR9810027-0A patent/BR9810027A/pt not_active Application Discontinuation
- 1998-06-08 IL IL13340598A patent/IL133405A0/xx unknown
- 1998-06-08 CA CA002293815A patent/CA2293815C/en not_active Expired - Lifetime
- 1998-06-08 RU RU2000100940/14A patent/RU2193880C2/ru active
- 1998-06-08 JP JP50196099A patent/JP5093937B2/ja not_active Expired - Lifetime
- 1998-06-08 DE DE69826660T patent/DE69826660T2/de not_active Expired - Lifetime
- 1998-06-08 ES ES98921690T patent/ES2226128T3/es not_active Expired - Lifetime
- 1998-06-08 CN CN98806116A patent/CN1274279A/zh active Pending
- 1998-06-08 PL PL98337813A patent/PL337813A1/xx not_active Application Discontinuation
- 1998-06-10 ZA ZA985010A patent/ZA985010B/xx unknown
- 1998-06-10 PE PE1998000490A patent/PE82999A1/es not_active IP Right Cessation
- 1998-06-10 US US09/095,322 patent/US6165513A/en not_active Expired - Lifetime
- 1998-06-11 AR ARP980102774A patent/AR027158A1/es not_active Application Discontinuation
- 1998-06-11 CO CO98033551A patent/CO4940409A1/es unknown
- 1998-06-11 MY MYPI98002615A patent/MY127526A/en unknown
- 1998-07-02 TW TW087110727A patent/TW542725B/zh not_active IP Right Cessation
-
1999
- 1999-12-09 IL IL133405A patent/IL133405A/en not_active IP Right Cessation
- 1999-12-10 NO NO19996116A patent/NO996116L/no not_active Application Discontinuation
-
2000
- 2000-09-26 HK HK00106110A patent/HK1028187A1/xx not_active IP Right Cessation
- 2000-10-23 US US09/694,799 patent/US6569460B1/en not_active Expired - Lifetime
-
2003
- 2003-03-28 US US10/401,352 patent/US20030211156A1/en not_active Abandoned
-
2006
- 2006-12-01 US US11/607,241 patent/US20070071822A1/en not_active Abandoned
-
2010
- 2010-06-02 JP JP2010127107A patent/JP5229641B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-04 JP JP2012265555A patent/JP2013067642A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE277606T1 (de) | Filmüberzogene tablette für verbesserte verträglichkeit im oberen magen-darmtrakt | |
DK0966287T3 (da) | Oxacarbazepinfilmovertrukne tabletter | |
GB9924523D0 (en) | Database processor | |
IL142515A0 (en) | Pharmaceutical kit | |
ZA981029B (en) | Pharmaceutical agents. | |
IL150053A0 (en) | Pharmaceutical superdisintegrant | |
AU142851S (en) | Pharmaceutical kit | |
DE69814850D1 (de) | Paracetamol enthaltende schlickbare tablette | |
HUP0203585A3 (en) | Pharmaceutical combinations | |
HU9900154D0 (en) | Trovafloxacin mesilate tablet | |
GB9915231D0 (en) | Pharmaceutical complex | |
DE29617001U1 (de) | Tablette in Herzform | |
DE29813269U1 (de) | Tablette | |
IL141348A0 (en) | Transdermally delivered aspirin | |
GB9920010D0 (en) | Improved films | |
FR2796716B1 (fr) | Tablette d'orientation | |
DE29619768U1 (de) | Tablette in Kleeblattform | |
SI0966287T1 (en) | Oxacarbazepine film-coated tablets | |
CA83558S (en) | Pharmaceutical tablet | |
CA88762S (en) | Pharmaceutical tablet | |
CA80343S (en) | Pharmaceutical tablet | |
CZ2001512A3 (cs) | Transdermálně dodávaný aspirin | |
CA87695S (en) | Cigar display case | |
GB9901347D0 (en) | Drug testing | |
GB9927698D0 (en) | Therapeutic antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0989848 Country of ref document: EP |